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EBV is a common human pathogen, which infects ~90% of people and establishes a life-
long chronic infection. The clinical outcomes of acute infection can range from 
asymptomatic to severe immunopathology such as infectious mononucleosis (IM). 
However, for unknown reasons 5-10% of middle-aged adults (>35 years) remain EBV-
seronegative (EBV-SN) when the virus infects the vast majority of people, and is actively 
shed at high titers during chronic infection. Here we show that EBV-SN (ASN) HLA-A2+ 
middle-aged adults possess a unique IAV-M1-GIL58-66 memory CD8 T-cell response that 
cross-reacts with EBV lytic epitopes that differs from teenage EBV-SN (TSN) (18-19 
years) and EBV-seropositive (EBV-SP) adult donors. The five tested HLA-A2+ EBV-SN 
middle-aged adults had a significantly increased IAV-M158-66-GIL tetramer+ CD8 
frequency compared to EBV-SP donors. Upon exposure to EBV antigens in vitro both 
IAV-M158-66GIL/EBV-BMLF1280-288-GLC and IAV-M158-66-GIL/EBV-BRLF1109-117-YVL, 
functionally cross-reactive CD8+ responses could be detected in the peripheral blood of 
middle-aged EBV-SN donors, while only IAV-M1/EBV-YVL cross-reactive responses 
were detected in some teenage EBV-SN  or EBV-seropositive people . Surprisingly, 
these IAV-M1-GIL-specific CD8 T-cells in middle-aged EBV-SN adults expanded 
dramatically to EBV lytic antigens and produced cytokines at high functional avidity. 
They lysed EBV-infected targets and showed potential (by CD103 expression) to enter 
mucosal epithelial tissue where infection initiates. Additionally, these cross-reactive cells 
had an oligo-clonal T-cell receptor repertoire different than EBV-SP donors. Taken 
together these data suggest that an altered cross-reactive T cell repertoire could 
mediate protective immunity against viral infection. Our results imply that sero-negative 
adults might have the ability to resist viral infection via heterologous immunity. (NIH-
AI49320).  
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